First FDA-approved CRISPR treatment: What are ethical concerns?

A groundbreaking approval from the FDA allows the gene-editing tool CRISPR to treat sickle cell disease. But many unknowns exist in using CRISPR to treat illnesses. 

Credits

Guest:

  • Brendan Parent - assistant professor of medical ethics at NYU Grossman School of Medicine; director of transplant ethics and policy research

Host:

Madeleine Brand

Producers:

Sarah Sweeney, Angie Perrin, Michell Eloy, Amy Ta, Brian Hardzinski, Bennett Purser, Nihar Patel